Vanda Pharmaceuticals
VNDA
VNDA
178 hedge funds and large institutions have $544M invested in Vanda Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 53 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.48% less ownership
Funds ownership: 98.99% → 97.51% (-1.5%)
11% less capital invested
Capital invested by funds: $611M → $544M (-$66.4M)
Holders
178
Holding in Top 10
–
Calls
$882K
Puts
$231K
Top Buyers
| 1 | +$6.42M | |
| 2 | +$3.3M | |
| 3 | +$2M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$1.67M |
| 5 |
Bank of New York Mellon
New York
|
+$1.55M |
Top Sellers
| 1 | -$11M | |
| 2 | -$9.89M | |
| 3 | -$3.6M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$3.43M |
| 5 |
Walleye Capital
New York
|
-$2.12M |